Q3: 9% organic growth, but only 2% EBIT growth. Room for further upside to organic growth guidance. Demanding 36x P/E and too little clarity = HOLD.

01 Aug 2023
Too many questions, too few answers

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Too many questions, too few answers
- Published:
01 Aug 2023 -
Author:
ABGSC Healthcare Research | Morten Larsen | Benjamin Silverstone -
Pages:
12 -
Q3: 9% organic growth, but only 2% EBIT growth. Room for further upside to organic growth guidance. Demanding 36x P/E and too little clarity = HOLD.